NCT06818149View on ClinicalTrials.gov

Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

February 1, 2025

Study Completion Date

December 30, 2028

Conditions
Lung CancerMyocarditis Due to Drug
Interventions
DIAGNOSTIC_TEST

Biomarker Analysis for Severity Assessment

Blood samples will be collected at baseline and at follow-up time points (3 days, 7 days, and before discharge). Traditional myocardial injury biomarkers, iron metabolism-related biomarkers, and immunological biomarkers will be tested.

Trial Locations (1)

Unknown

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Chest Hospital

OTHER